Treat Ankylosing Spondylitis with Methazolamide
<p><b>Background:</b> Increased bone resorption and new bone information are two characteristics of ankylosing spondylitis (AS). Much evidence has shown that carbonic anhydrase inhibitors can restrain bone resorption. We had detected increased expression of carbonic anhydrase I (CA...
Main Author: | Xiaotian Chang, Xinfeng Yan, Yunzhong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | International Journal of Medical Sciences |
Online Access: | http://www.medsci.org/v08p0413.htm |
Similar Items
-
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA
by: Tao Sun, et al.
Published: (2023-09-01) -
Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis
by: Cui Yazhou, et al.
Published: (2010-12-01) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01) -
ANKYLOSING SPONDYLITIS
by: I. V. Soldatenko
Published: (2013-12-01) -
Carbonic Anhydrase 1-Mediated Calcification Is Associated With Atherosclerosis, and Methazolamide Alleviates Its Pathogenesis
by: Lin Yuan, et al.
Published: (2019-07-01)